Philippe Conus1,2, Sue Cotton3,4, Benno G Schimmelmann5,6, Patrick D McGorry3,4, Martin Lambert6. 1. Treatment and Early Intervention in Psychosis Program (TIPP), Département de Psychiatrie CHUV, Université de Lausanne, Clinique de Cery, 1008, Prilly, Switzerland. philippe.conus@chuv.ch. 2. Orygen Youth Health Research Centre, 35 Poplar Road, Parkville Victoria, Melbourne, 3052, Australia. philippe.conus@chuv.ch. 3. Orygen Youth Health Research Centre, 35 Poplar Road, Parkville Victoria, Melbourne, 3052, Australia. 4. Centre for Youth Mental Health University of Melbourne, 35 Poplar Road, Parkville Victoria, Melbourne, 3052, Australia. 5. Department of Child- and Adolescent Psychiatry, University of Bern, Bern, Switzerland. 6. Psychosis Early Detection and Intervention Centre (PEDIC), Department for Psychiatry and Psychotherapy, Centre for Psychosocial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Abstract
OBJECTIVES: Most first episode psychosis (FEP) outcome studies are based on patient samples enrolled through an informed consent procedure, which may induce important biases. Our aim was to study the 18-month outcome of FEP in an epidemiological sample of patients treated at the Early Psychosis Prevention and Intervention Centre (EPPIC). METHODS: The files of 661 FEP patients treated for up to 18 months between 1998 and 2000 were assessed. Symptomatic remission was defined as receiving a score ≤3 on the Clinical Global Impressions (CGI) scales, and functional remission as concurrent fulfillment of occupation/employment and independent living. Predictors were analyzed using stepwise logistic regression models. RESULTS: At endpoint, 63% of FEP patients had reached symptomatic remission and 44% functional remission. Duration of untreated psychosis, baseline symptom intensity, time in service and decrease or remission of substance use, predicted both symptomatic and functional outcome. A history of suicide attempt or non-adherence to medication was linked to lower likelihood to reach symptomatic remission while pre-morbid GAF and employment at baseline were linked to functional outcome. CONCLUSIONS: The development of early intervention strategies should be pursued, in order both to provide treatment before symptoms reach a high intensity and to maintain social integration. Specific strategies need to promote engagement, facilitate adherence to medication and to create a framework where key issues such as substance abuse co-morbidity can be addressed.
OBJECTIVES: Most first episode psychosis (FEP) outcome studies are based on patient samples enrolled through an informed consent procedure, which may induce important biases. Our aim was to study the 18-month outcome of FEP in an epidemiological sample of patients treated at the Early Psychosis Prevention and Intervention Centre (EPPIC). METHODS: The files of 661 FEP patients treated for up to 18 months between 1998 and 2000 were assessed. Symptomatic remission was defined as receiving a score ≤3 on the Clinical Global Impressions (CGI) scales, and functional remission as concurrent fulfillment of occupation/employment and independent living. Predictors were analyzed using stepwise logistic regression models. RESULTS: At endpoint, 63% of FEP patients had reached symptomatic remission and 44% functional remission. Duration of untreated psychosis, baseline symptom intensity, time in service and decrease or remission of substance use, predicted both symptomatic and functional outcome. A history of suicide attempt or non-adherence to medication was linked to lower likelihood to reach symptomatic remission while pre-morbid GAF and employment at baseline were linked to functional outcome. CONCLUSIONS: The development of early intervention strategies should be pursued, in order both to provide treatment before symptoms reach a high intensity and to maintain social integration. Specific strategies need to promote engagement, facilitate adherence to medication and to create a framework where key issues such as substance abuse co-morbidity can be addressed.
Entities:
Keywords:
First episode psychosis; Functioning; Outcome; Predictors; Schizophrenia; Symptoms
Authors: Lone Petersen; Anne Thorup; Johan Øqhlenschlaeger; Torben Øqstergaard Christensen; Pia Jeppesen; Gertrud Krarup; Per Jørrgensen; Erik Lykke Mortensen; Merete Nordentoft Journal: Can J Psychiatry Date: 2008-10 Impact factor: 4.356
Authors: Ross M G Norman; Rahul Manchanda; Ashok K Malla; Deborah Windell; Raj Harricharan; Sandra Northcott Journal: Schizophr Res Date: 2011-05-05 Impact factor: 4.939
Authors: M Tohen; S M Strakowski; C Zarate; J Hennen; A L Stoll; T Suppes; G L Faedda; B M Cohen; P Gebre-Medhin; R J Baldessarini Journal: Biol Psychiatry Date: 2000-09-15 Impact factor: 13.382
Authors: Mara De Maio; Patricia Graham; David Vaughan; Lawrence Haber; Steven Madonick Journal: Early Interv Psychiatry Date: 2014-02-27 Impact factor: 2.732
Authors: Emily Kline; Victoria Hendel; Michelle Friedman-Yakoobian; Raquelle I Mesholam-Gately; Ann Findeisen; Suzanna Zimmet; Joanne D Wojcik; Tracey L Petryshen; Tsung-Ung W Woo; Jill M Goldstein; Martha E Shenton; Matcheri S Keshavan; Robert W McCarley; Larry J Seidman Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-11-28 Impact factor: 4.328
Authors: Christina D Kang-Yi; Brian Chao; Shelly Teng; Jill Locke; David S Mandell; Yin-Ling Irene Wong; C Neill Epperson Journal: Front Psychiatry Date: 2020-06-04 Impact factor: 4.157
Authors: Margot Fournier; Martina Scolamiero; Mehdi M Gholam-Rezaee; Martine Cleusix; Raoul Jenni; Carina Ferrari; Philippe Golay; Philipp S Baumann; Michel Cuenod; Philippe Conus; Kim Q Do; Kathryn Hess Journal: Mol Psychiatry Date: 2020-07-06 Impact factor: 15.992